Refine your search
445 results found
Lexology PRO | Turkey | 1 Dec 2023
GSK, AstraZeneca, Johnson & Johnson and others raided in Turkish labour market probe
Turkey’s Competition Authority has launched a sprawling investigation into 19 companies, including AstraZeneca, Johnson & Johnson, Pfizer, GlaxoSmithKline and Panasonic, for allegedly forming no-poach agreements in the pharmaceutical sector.
Hunton Andrews Kurth LLP | USA | 7 Mar 2023
Boots on the Ground or Hands on a Keyboard: Merck and Insurers Battle Out the War Exclusion
On June 27, 2017, the skies over New Jersey were clear and the ground steady. But Merck & Co., a New Jersey-based pharmaceutical company, was under…
Smart & Biggar | Canada | 23 Mar 2022
Court declares confidential rebate reporting and new price regulatory factors of amended Patented Medicines Regulations invalid
The Quebec Court of Appeal recently released its decision in Merck Canada Inc v Procureur général du Canada. This is the appeal of the Quebec Superior Court decision declaring price and revenue calculation provisions of the amended Patented Medicines Regulations unconstitutional. The Quebec Court of Appeal declared ultra vires, invalid and of no effect new paragraphs 4(4)(a) and (b) and new......
Fenwick & West LLP | USA | 18 Dec 2018
Patent Owners Win as Federal Circuit Reins in Gilead and AbbVie Double Patenting Rulings
In a pair of patent owner victories, the U.S. Court of Appeals for the Federal Circuit issued decisions limiting the applicability of obviousness-type…
AA Thornton IP LLP | Global | 3 Oct 2018
WIPO Magazine has announced the launch of a new tool linking patents and drugs: Pat-INFORMED
The World Intellectual Property Organization (WIPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)…
Seyfarth Shaw LLP | USA | 15 Aug 2018
Federal Court Leaves Opportunity For A “Compelling” Exhaustion Argument
The U.S. District Court for the District of New Jersey recently issued a ruling with respect to Defendants’ “compelling” exhaustion…
Grau & Angulo | Spain | 7 May 2018
Barcelona patent court revokes preliminary injunction granted ex parte in NuvaRing case
Barcelona Commercial Court Number 5 recently revoked a preliminary injunction which had been granted ex parte at the request of Merck Sharp & Dohme BV (MSD) for alleged patent infringement. This case is notable, as the defendants' product – which is the first competitor of MSD's contraceptive vaginal ring, NuvaRing – is manufactured in Spain and sold in several European countries where other......
Morrison & Foerster LLP | USA | 7 May 2018
Hatch-Waxman and BPCIA Developments for April 2018
This month, we highlight several significant cases, including the Supreme Court’s decisions in Oil States and SAS, and the Federal Circuit’s decisions…
Banner Witcoff | USA | 2 May 2018
Is Functional Similarity Between Compounds Sufficient to Create a Prima Facie Case of Obviousness?
Anacor Pharmaceuticals, the dissatisfied patent owner in an inter partes review (IPR), and the U.S. Patent and Trademark Office (USPTO) as intervenor…
Rothwell, Figg, Ernst & Manbeck, PC | USA | 3 Apr 2018
Global Approvals for Insulin Glargine Promise a More Affordable, Long-Acting Treatment for Diabetes
Last week, Mylan N.V. and Biocon Ltd. announced that their jointly-developed insulin glargine biosimilar, Semglee™, received marketing approval from…
